BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25677816)

  • 1. S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.
    Che P; Yang Y; Han X; Hu M; Sellers JC; Londono-Joshi AI; Cai GQ; Buchsbaum DJ; Christein JD; Tang Q; Chen D; Li Q; Grizzle WE; Lu YY; Ding Q
    Sci Rep; 2015 Feb; 5():8453. PubMed ID: 25677816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells.
    Xu X; Su B; Xie C; Wei S; Zhou Y; Liu H; Dai W; Cheng P; Wang F; Xu X; Guo C
    PLoS One; 2014; 9(7):e96441. PubMed ID: 25072505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
    Wang XG; Meng Q; Qi FM; Yang QF
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
    Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
    Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.
    Tabata T; Tsukamoto N; Fooladi AA; Yamanaka S; Furukawa T; Ishida M; Sato D; Gu Z; Nagase H; Egawa S; Sunamura M; Horii A
    Biochem Biophys Res Commun; 2009 Dec; 390(3):475-80. PubMed ID: 19799859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells.
    Chen M; Sastry SK; O'Connor KL
    Am J Physiol Cell Physiol; 2011 May; 300(5):C1155-63. PubMed ID: 21289293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.
    Li N; Song MM; Chen XH; Liu LH; Li FS
    Biomed Environ Sci; 2012 Aug; 25(4):465-70. PubMed ID: 23026527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
    Liu J; Fu S; Xu Y; Zheng Z
    Mol Med Rep; 2014 Sep; 10(3):1389-94. PubMed ID: 24969174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling.
    Zhengfu H; Hu Z; Huiwen M; Zhijun L; Jiaojie Z; Xiaoyi Y; Xiujun C
    Biochem Biophys Res Commun; 2015 Aug; 464(2):422-7. PubMed ID: 26102035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src.
    Lee YH; Kayyali US; Sousa AM; Rajan T; Lechleider RJ; Day RM
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):485-93. PubMed ID: 17585111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo.
    Hua J; Chen D; Fu H; Zhang R; Shen W; Liu S; Sun K; Sun X
    Cancer Lett; 2010 Jun; 292(1):41-7. PubMed ID: 19945782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between S100A11 and the TGF-β
    Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
    Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells.
    Sekine H; Chen N; Sato K; Saiki Y; Yoshino Y; Umetsu Y; Jin G; Nagase H; Gu Z; Fukushige S; Sunamura M; Horii A
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):214-9. PubMed ID: 23085231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
    Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
    Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells.
    Wu D; Shi Z; Xu H; Chen R; Xue S; Sun X
    J Biosci; 2017 Sep; 42(3):405-416. PubMed ID: 29358554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
    Gomes EG; Connelly SF; Summy JM
    Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.